Increased serum level of prolactin is related to autoantibody production in systemic lupus erythematosus.
- Published in:
- Lupus, 2016, v. 25, n. 5, p. 513, doi. 10.1177/0961203315622276
- By:
- Publication type:
- Article
Works matching IS 09612033 AND DT 2016 AND VI 25 AND IP 5
Results: 15
1
2
Successful treatment of severe refractory lupus hepatitis with mycophenolate mofetil.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
3
Iloprost treatment in pediatric patients with complicated Raynaud's phenomenon.
- Published in:
- 2016
- By:
- Publication type:
- Letter to the Editor
4
Assessment of premature atherosclerosis in systemic lupus erythematosus patients with and without nephritis.
- Published in:
- Lupus, 2016, v. 25, n. 5, p. 525, doi. 10.1177/0961203315622822
- By:
- Publication type:
- Article
5
The spectrum of nasal involvement in systemic lupus erythematosus and its association with the disease activity.
- Published in:
- Lupus, 2016, v. 25, n. 5, p. 520, doi. 10.1177/0961203315622279
- By:
- Publication type:
- Article
6
Musculoskeletal manifestations of the antiphospholipid syndrome.
- Published in:
- Lupus, 2016, v. 25, n. 5, p. 451, doi. 10.1177/0961203316636467
- By:
- Publication type:
- Article
7
Anti-Ro/SSA autoantibody-positive women’s experience of information given on the risk of congenital heart block.
- Published in:
- Lupus, 2016, v. 25, n. 5, p. 536, doi. 10.1177/0961203315620760
- By:
- Publication type:
- Article
8
Outcome of lupus nephritis in childhood onset SLE in North and Central India: single-centre experience over 25 years.
- Published in:
- Lupus, 2016, v. 25, n. 5, p. 547, doi. 10.1177/0961203315619031
- By:
- Publication type:
- Article
9
Understanding remission in real-world lupus patients across five European countries.
- Published in:
- Lupus, 2016, v. 25, n. 5, p. 505, doi. 10.1177/0961203315619030
- By:
- Publication type:
- Article
10
Evaluation of left atrial function by speckle tracking echocardiography in patients with systemic lupus erythematosus.
- Published in:
- Lupus, 2016, v. 25, n. 5, p. 496, doi. 10.1177/0961203315619029
- By:
- Publication type:
- Article
11
Antimalarials as a risk factor for elevated muscle enzymes in systemic lupus erythematosus.
- Published in:
- Lupus, 2016, v. 25, n. 5, p. 532, doi. 10.1177/0961203315617845
- By:
- Publication type:
- Article
12
Validation of the Japanese version of the Systemic Lupus Activity Questionnaire that includes physician-based assessments in a large observational cohort.
- Published in:
- Lupus, 2016, v. 25, n. 5, p. 486, doi. 10.1177/0961203315617844
- By:
- Publication type:
- Article
13
Primary antiphospholipid syndrome: absence of premature atherosclerosis in patients without traditional coronary artery disease risk factors.
- Published in:
- Lupus, 2016, v. 25, n. 5, p. 472, doi. 10.1177/0961203315617841
- By:
- Publication type:
- Article
14
Patients with antiphosholipid syndrome and thrombotic recurrences: A real world observation (the Piedmont cohort study).
- Published in:
- Lupus, 2016, v. 25, n. 5, p. 479, doi. 10.1177/0961203315617538
- By:
- Publication type:
- Article
15
Psychological distress in corticosteroid-naive patients with systemic lupus erythematosus: A prospective cross-sectional study.
- Published in:
- Lupus, 2016, v. 25, n. 5, p. 463, doi. 10.1177/0961203315615223
- By:
- Publication type:
- Article